Organon (OGN) Tax Provisions (2020 - 2026)
Organon (OGN) posted quarterly Tax Provisions of $67.0 million for Q1 2026, up 378.57% year-over-year from $14.0 million in Q1 2025, and up 17.54% on a QoQ basis from $57.0 million in Q4 2025.
Organon (OGN) Tax Provisions (2020 - 2026) Analysis & Trends
Organon (OGN) has reported Tax Provisions for 7 consecutive years, with $67.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions rose 378.57% year-over-year to $67.0 million; the TTM figure through Mar 2026 stood at $291.0 million (up 473.08% YoY), while the FY2025 annual figure was $238.0 million, up 517.54% from the prior year.
- Tax Provisions came in at $67.0 million for Q1 2026 at Organon, up from $57.0 million in the prior quarter.
- The five-year high for Tax Provisions was $94.0 million in Q1 2022, with the low at -$442.0 million in Q4 2023.
- Average Tax Provisions over 5 years is $7.1 million, with a median of $40.0 million recorded in 2024.
- Across the five-year window, Tax Provisions jumped 783.33% in 2022 and slumped 2204.76% in 2023, its largest moves.
- Year by year, Tax Provisions stood at $21.0 million in 2022, then plunged by 2204.76% to -$442.0 million in 2023, then surged by 104.52% to $20.0 million in 2024, then surged by 185.0% to $57.0 million in 2025, then grew by 17.54% to $67.0 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $67.0 million, $57.0 million, and $83.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.45 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 755.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 342.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 3.08 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 709.00 Mn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 265.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 559.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 461.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -683.00 Mn |
| 10 | Organon | 3.53 Bn | 2.41 Bn | 783.00 Mn | 67.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.00 Mn |
| Dec 31, 2025 | 57.00 Mn |
| Sep 30, 2025 | 83.00 Mn |
| Jun 30, 2025 | 84.00 Mn |
| Mar 31, 2025 | 14.00 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | -152.00 Mn |
| Jun 30, 2024 | 40.00 Mn |
| Mar 31, 2024 | 35.00 Mn |
| Dec 31, 2023 | -442.00 Mn |
| Sep 30, 2023 | 22.00 Mn |
| Jun 30, 2023 | 12.00 Mn |
| Mar 31, 2023 | 58.00 Mn |
| Dec 31, 2022 | 21.00 Mn |
| Sep 30, 2022 | 55.00 Mn |
| Jun 30, 2022 | 53.00 Mn |
| Mar 31, 2022 | 94.00 Mn |
| Dec 31, 2021 | 34.00 Mn |
| Sep 30, 2021 | 66.00 Mn |
| Jun 30, 2021 | 6.00 Mn |